[
  {
    "ts": null,
    "headline": "S&P Behemoth Danaher Surges On Plans To Navigate Pharma-Tied Tariffs",
    "summary": "Danaher stock jumped Tuesday after the medical powerhouse delivered a \"solid\" first-quarter report and maintained its outlook for the year.",
    "url": "https://finnhub.io/api/news?id=76ec02dc9fef615015415bb1267e0c8448c624e9e4ca1f5446a9ac6fa4da996c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745352349,
      "headline": "S&P Behemoth Danaher Surges On Plans To Navigate Pharma-Tied Tariffs",
      "id": 134039059,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "Danaher stock jumped Tuesday after the medical powerhouse delivered a \"solid\" first-quarter report and maintained its outlook for the year.",
      "url": "https://finnhub.io/api/news?id=76ec02dc9fef615015415bb1267e0c8448c624e9e4ca1f5446a9ac6fa4da996c"
    }
  },
  {
    "ts": null,
    "headline": "Danaher (DHR) Stock Trades Up, Here Is Why",
    "summary": "Shares of diversified science and technology company Danaher (NYSE:DHR) jumped 6.6% in the afternoon session after the company reported impressive first quarter 2025 results, which beat analysts' organic revenue and EPS expectations. Revenue was flat year-over-year on a core basis, which masked a 7% gain in biotech and a modest decline in life sciences, revealing the uneven recovery across business lines. Looking ahead, sales guidance for the next quarter was ahead, while full year EPS guidance",
    "url": "https://finnhub.io/api/news?id=b7e40b211c857a83551194fe1826280956fa959da3390b5c743d865e97163261",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745346133,
      "headline": "Danaher (DHR) Stock Trades Up, Here Is Why",
      "id": 134039060,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "Shares of diversified science and technology company Danaher (NYSE:DHR) jumped 6.6% in the afternoon session after the company reported impressive first quarter 2025 results, which beat analysts' organic revenue and EPS expectations. Revenue was flat year-over-year on a core basis, which masked a 7% gain in biotech and a modest decline in life sciences, revealing the uneven recovery across business lines. Looking ahead, sales guidance for the next quarter was ahead, while full year EPS guidance",
      "url": "https://finnhub.io/api/news?id=b7e40b211c857a83551194fe1826280956fa959da3390b5c743d865e97163261"
    }
  },
  {
    "ts": null,
    "headline": "Danaher Corp. stock outperforms competitors on strong trading day",
    "summary": "Danaher Corp. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=da3ee486020d5c20c33e8aeae1122d1a2312fae27b42880d17f10e4b933ddb7a",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745339760,
      "headline": "Danaher Corp. stock outperforms competitors on strong trading day",
      "id": 134055576,
      "image": "",
      "related": "DHR",
      "source": "MarketWatch",
      "summary": "Danaher Corp. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=da3ee486020d5c20c33e8aeae1122d1a2312fae27b42880d17f10e4b933ddb7a"
    }
  },
  {
    "ts": null,
    "headline": "Danaher Q1 Earnings Beat Estimates, Life Sciences Sales Down Y/Y",
    "summary": "DHR's first-quarter sales decrease 1% year over year, due to the lackluster performance of its Life Sciences and Biotechnology segments.",
    "url": "https://finnhub.io/api/news?id=682e4d5264d78a887e9d10d6fcb51ffc0b878c432903a4a33e3e780a485d0555",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745338440,
      "headline": "Danaher Q1 Earnings Beat Estimates, Life Sciences Sales Down Y/Y",
      "id": 134039061,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "DHR's first-quarter sales decrease 1% year over year, due to the lackluster performance of its Life Sciences and Biotechnology segments.",
      "url": "https://finnhub.io/api/news?id=682e4d5264d78a887e9d10d6fcb51ffc0b878c432903a4a33e3e780a485d0555"
    }
  },
  {
    "ts": null,
    "headline": "Danaher Fiscal First-Quarter Results Top Views; Forecasts Core Revenue Growth",
    "summary": "Danaher (DHR) on Tuesday reported better-than-expected fiscal first-quarter results, while the medic",
    "url": "https://finnhub.io/api/news?id=657672d82b1efaa858a651e35b482b75203799ca0a0aef52517619cc25eca23b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745333816,
      "headline": "Danaher Fiscal First-Quarter Results Top Views; Forecasts Core Revenue Growth",
      "id": 134039062,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "Danaher (DHR) on Tuesday reported better-than-expected fiscal first-quarter results, while the medic",
      "url": "https://finnhub.io/api/news?id=657672d82b1efaa858a651e35b482b75203799ca0a0aef52517619cc25eca23b"
    }
  },
  {
    "ts": null,
    "headline": "Danaher (DHR) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates",
    "summary": "The headline numbers for Danaher (DHR) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.",
    "url": "https://finnhub.io/api/news?id=9be5aad126687b379801f8b9f0694f821b23cf3d969359998206495055cdb625",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745328620,
      "headline": "Danaher (DHR) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates",
      "id": 134039063,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "The headline numbers for Danaher (DHR) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.",
      "url": "https://finnhub.io/api/news?id=9be5aad126687b379801f8b9f0694f821b23cf3d969359998206495055cdb625"
    }
  },
  {
    "ts": null,
    "headline": "Danaher sees net income and revenue decline in first quarter",
    "summary": "Danaher sees net income and revenue decline in first quarter",
    "url": "https://finnhub.io/api/news?id=5ad82ffa278486dc1e0f0d56b9597781464e5558c7b163ce70a22ede5820d497",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745320981,
      "headline": "Danaher sees net income and revenue decline in first quarter",
      "id": 134031772,
      "image": "",
      "related": "DHR",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=5ad82ffa278486dc1e0f0d56b9597781464e5558c7b163ce70a22ede5820d497"
    }
  },
  {
    "ts": null,
    "headline": "Danaher Corporation 2025 Q1 - Results - Earnings Call Presentation",
    "summary": "Danaher Corporation 2025 Q1 - Results - Earnings Call Presentation",
    "url": "https://finnhub.io/api/news?id=5239275e6eafade2fb72163952ec1e0afa1af3b27c08743e18530eaee92db524",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745320232,
      "headline": "Danaher Corporation 2025 Q1 - Results - Earnings Call Presentation",
      "id": 134033959,
      "image": "",
      "related": "DHR",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=5239275e6eafade2fb72163952ec1e0afa1af3b27c08743e18530eaee92db524"
    }
  },
  {
    "ts": null,
    "headline": "Danaher (DHR) Surpasses Q1 Earnings and Revenue Estimates",
    "summary": "Danaher (DHR) delivered earnings and revenue surprises of 16.05% and 3.34%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=6a426853150518a5052fe4c0068117b7a505fb4600648b9f8ee168bc2acff9f7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745320206,
      "headline": "Danaher (DHR) Surpasses Q1 Earnings and Revenue Estimates",
      "id": 134039064,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "Danaher (DHR) delivered earnings and revenue surprises of 16.05% and 3.34%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=6a426853150518a5052fe4c0068117b7a505fb4600648b9f8ee168bc2acff9f7"
    }
  },
  {
    "ts": null,
    "headline": "Danaher Corporation (DHR) Q1 2025 Earnings Call Transcript",
    "summary": "Danaher Corporation (DHR) Q1 2025 Earnings Call Transcript",
    "url": "https://finnhub.io/api/news?id=f9e732fed2350ae99940464b04400cb11147482c18f7f8ada2a898e4920ad2d0",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745320187,
      "headline": "Danaher Corporation (DHR) Q1 2025 Earnings Call Transcript",
      "id": 134033960,
      "image": "",
      "related": "DHR",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=f9e732fed2350ae99940464b04400cb11147482c18f7f8ada2a898e4920ad2d0"
    }
  },
  {
    "ts": null,
    "headline": "Danaher (NYSE:DHR) Surprises With Q1 Sales, Next Quarter’s Sales Guidance is Optimistic",
    "summary": "Diversified science and technology company Danaher (NYSE:DHR) reported Q1 CY2025 results beating Wall Street’s revenue expectations, but sales were flat year on year at $5.74 billion. Guidance for next quarter’s revenue was better than expected at $5.92 billion at the midpoint, 1.9% above analysts’ estimates. Its non-GAAP profit of $1.88 per share was 14.4% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=e7bdcc617552a17f43e2eae1d78d7fe9fea04078b707da46248473d8ff834da7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745317034,
      "headline": "Danaher (NYSE:DHR) Surprises With Q1 Sales, Next Quarter’s Sales Guidance is Optimistic",
      "id": 134032007,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "Diversified science and technology company Danaher (NYSE:DHR) reported Q1 CY2025 results beating Wall Street’s revenue expectations, but sales were flat year on year at $5.74 billion. Guidance for next quarter’s revenue was better than expected at $5.92 billion at the midpoint, 1.9% above analysts’ estimates. Its non-GAAP profit of $1.88 per share was 14.4% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=e7bdcc617552a17f43e2eae1d78d7fe9fea04078b707da46248473d8ff834da7"
    }
  },
  {
    "ts": null,
    "headline": "Danaher: Q1 Earnings Snapshot",
    "summary": "WASHINGTON (AP) — Danaher Corp. DHR) on Tuesday reported first-quarter profit of $954 million. The Washington-based company said it had profit of $1.32 per share.",
    "url": "https://finnhub.io/api/news?id=80c2b42fa73e13277c39b5c5aed75bb606562811c6030e7c77e2eae91e9ccb73",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745316453,
      "headline": "Danaher: Q1 Earnings Snapshot",
      "id": 134032008,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "WASHINGTON (AP) — Danaher Corp. DHR) on Tuesday reported first-quarter profit of $954 million. The Washington-based company said it had profit of $1.32 per share.",
      "url": "https://finnhub.io/api/news?id=80c2b42fa73e13277c39b5c5aed75bb606562811c6030e7c77e2eae91e9ccb73"
    }
  },
  {
    "ts": null,
    "headline": "Danaher Reports First Quarter 2025 Results",
    "summary": "Danaher Corporation (NYSE: DHR) (the \"Company\") today announced results for the quarter ended March 28, 2025.",
    "url": "https://finnhub.io/api/news?id=e397ca38675fb586073a1a2e365d5580bcf714282bf11a79cf5db400583cab4e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745316000,
      "headline": "Danaher Reports First Quarter 2025 Results",
      "id": 134032009,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "Danaher Corporation (NYSE: DHR) (the \"Company\") today announced results for the quarter ended March 28, 2025.",
      "url": "https://finnhub.io/api/news?id=e397ca38675fb586073a1a2e365d5580bcf714282bf11a79cf5db400583cab4e"
    }
  },
  {
    "ts": null,
    "headline": "Earnings season is off to a lackluster start: DataTrek",
    "summary": "Earnings season is off to a lackluster start: DataTrek",
    "url": "https://finnhub.io/api/news?id=6c534e6ffe1716548bb5e8567b48ef268c8b7b6e8e3524d6259e77043782219a",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745310350,
      "headline": "Earnings season is off to a lackluster start: DataTrek",
      "id": 134053828,
      "image": "",
      "related": "DHR",
      "source": "MarketWatch",
      "summary": "Earnings season is off to a lackluster start: DataTrek",
      "url": "https://finnhub.io/api/news?id=6c534e6ffe1716548bb5e8567b48ef268c8b7b6e8e3524d6259e77043782219a"
    }
  },
  {
    "ts": null,
    "headline": "Danaher 1Q Results Decline But Top Estimates",
    "summary": "By Denny Jacob Danaher posted improved results across key metrics in its latest quarter, which it attributed to momentum in its bioprocessing unit and demand above expectations in its molecular...",
    "url": "https://finnhub.io/api/news?id=79c710f8c381d1ee73b658cd45e687bd9833910767c8081e72d30903e967b517",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745303735,
      "headline": "Danaher 1Q Results Decline But Top Estimates",
      "id": 134031164,
      "image": "",
      "related": "DHR",
      "source": "Finnhub",
      "summary": "By Denny Jacob Danaher posted improved results across key metrics in its latest quarter, which it attributed to momentum in its bioprocessing unit and demand above expectations in its molecular...",
      "url": "https://finnhub.io/api/news?id=79c710f8c381d1ee73b658cd45e687bd9833910767c8081e72d30903e967b517"
    }
  },
  {
    "ts": null,
    "headline": "Tesla kicks off Mag 7 results as earnings season picks up speed",
    "summary": "Tesla kicks off Mag 7 results as earnings season picks up speed",
    "url": "https://finnhub.io/api/news?id=f974af1083a211370250a3f30b0ccc82386f0e139421c985efb0e0c1821d220f",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745298189,
      "headline": "Tesla kicks off Mag 7 results as earnings season picks up speed",
      "id": 134053830,
      "image": "",
      "related": "DHR",
      "source": "MarketWatch",
      "summary": "Tesla kicks off Mag 7 results as earnings season picks up speed",
      "url": "https://finnhub.io/api/news?id=f974af1083a211370250a3f30b0ccc82386f0e139421c985efb0e0c1821d220f"
    }
  }
]